Format

Send to

Choose Destination
EMBO Mol Med. 2013 Feb;5(2):309-25. doi: 10.1002/emmm.201201546. Epub 2013 Jan 9.

The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling.

Author information

1
Institut Curie, Paris, France; CNRS UMR 3306, Orsay, France.

Abstract

In Huntington disease (HD), polyglutamine expansion in the huntingtin protein causes specific neuronal death. The consequences of the presence of mutant huntingtin in other tissues are less well understood. Here we propose that mutant huntingtin influences breast cancer progression. Indeed, we show that mammary tumours appear earlier in mouse breast cancer models expressing mutant huntingtin as compared to control mice expressing wild-type huntingtin. Tumours bearing mutant huntingtin have a modified gene expression pattern that reflects enhanced aggressiveness with the overexpression of genes favouring invasion and metastasis. In agreement, mutant huntingtin accelerates epithelial to mesenchymal transition and enhances cell motility and invasion. Also, lung metastasis is higher in HD conditions than in control mice. Finally, we report that in HD, the dynamin dependent endocytosis of the ErbB2/HER2 receptor tyrosine kinase is reduced. This leads to its accumulation and to subsequent increases in cell motility and proliferation. Our study may thus have important implications for both cancer and HD.

PMID:
23300147
PMCID:
PMC3569645
DOI:
10.1002/emmm.201201546
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center